About Bio-Rad Laboratories, Inc.
Bio-Rad Laboratories, Inc. (BIO) has been publicly traded since 1980, making it a 46-year-old public company. It operates in the Medical Devices industry within the Healthcare sector. The company is headquartered in Hercules, United States and employs approximately 7,450 people. With a market capitalization of $7.1 billion, BIO is a mid-sized company with growth potential.
Key Statistics
- Current Price
- $262.80
- Market Cap
- $7.09B
- 52-Week High
- $343.12
- 52-Week Low
- $211.43
- Sector
- Healthcare
- Industry
- Medical Devices
$1,000 Invested
Monthly Returns Heatmap
Annual Returns
| Year | Return | Start | End |
|---|---|---|---|
| 2026 | -13.26% | $302.99 | $262.80 |
| 2025 | -7.77% | $328.51 | $302.99 |
| 2024 | +1.74% | $322.89 | $328.51 |
| 2023 | -23.21% | $420.49 | $322.89 |
| 2022 | -44.35% | $755.57 | $420.49 |
| 2021 | +29.61% | $582.94 | $755.57 |
| 2020 | +57.54% | $370.03 | $582.94 |
| 2019 | +59.34% | $232.22 | $370.03 |
| 2018 | -2.70% | $238.67 | $232.22 |
| 2017 | +30.94% | $182.28 | $238.67 |
| 2016 | +31.46% | $138.66 | $182.28 |
| 2015 | +15.01% | $120.56 | $138.66 |
| 2014 | -2.47% | $123.61 | $120.56 |
| 2013 | +17.67% | $105.05 | $123.61 |
| 2012 | +9.38% | $96.04 | $105.05 |
| 2011 | -7.52% | $103.85 | $96.04 |
| 2010 | +7.66% | $96.46 | $103.85 |
| 2009 | +28.08% | $75.31 | $96.46 |
| 2008 | -27.32% | $103.62 | $75.31 |
| 2007 | +25.57% | $82.52 | $103.62 |
| 2006 | +26.10% | $65.44 | $82.52 |
| 2005 | +14.07% | $57.37 | $65.44 |
| 2004 | -0.52% | $57.67 | $57.37 |
| 2003 | +49.02% | $38.70 | $57.67 |
| 2002 | +22.27% | $31.65 | $38.70 |
| 2001 | +99.06% | $15.90 | $31.65 |
| 2000 | +36.04% | $11.69 | $15.90 |
| 1999 | +11.31% | $10.50 | $11.69 |
| 1998 | -19.62% | $13.06 | $10.50 |
| 1997 | -12.92% | $15.00 | $13.06 |
| 1996 | +5.88% | $14.17 | $15.00 |
| 1995 | +53.15% | $9.25 | $14.17 |
| 1994 | +177.50% | $3.33 | $9.25 |
| 1993 | -41.61% | $5.71 | $3.33 |
| 1992 | -13.29% | $6.58 | $5.71 |
| 1991 | +6.76% | $6.17 | $6.58 |
| 1990 | +15.63% | $5.33 | $6.17 |
| 1989 | -5.88% | $5.67 | $5.33 |
| 1988 | +11.48% | $5.08 | $5.67 |
| 1987 | -11.59% | $5.75 | $5.08 |
| 1986 | +13.74% | $5.06 | $5.75 |
| 1985 | +137.39% | $2.13 | $5.06 |
| 1984 | -14.81% | $2.50 | $2.13 |
| 1983 | +87.50% | $1.33 | $2.50 |
| 1982 | -7.69% | $1.44 | $1.33 |
| 1981 | -51.25% | $2.96 | $1.44 |
Valuation
BIO currently trades at a trailing P/E ratio of 9.4, which is considered low relative to the broader market. The forward P/E of 23.2 suggests analysts expect earnings to be higher in the coming year. The price-to-book ratio stands at 1.0. The price-to-sales ratio is 2.7.
Dividends
Bio-Rad Laboratories, Inc. does not currently pay a dividend, choosing to reinvest earnings back into the business for growth.
Risk & Volatility
BIO has a beta of 1.20, indicating it is significantly more volatile than the overall market. The stock's 52-week range is $211.43 to $343.12, and it currently trades in the lower half of its 52-week range.
Analyst Ratings
Based on 5 analyst opinions, BIO has a consensus "buy" rating. The average price target of $324.00 suggests 23.3% upside from current levels.
Frequently Asked Questions
What does Bio-Rad Laboratories, Inc. do? ▼
Bio-Rad Laboratories, Inc. is a Medical Devices company operating in the Healthcare sector. The company is headquartered in Hercules, United States.
What sector is BIO in? ▼
BIO operates in the Healthcare sector, specifically in the Medical Devices industry.
When did BIO go public? ▼
Bio-Rad Laboratories, Inc. went public in 1980, making it a 46-year-old public company as of 2026.
How much would $1,000 invested in BIO 5 years ago be worth today? ▼
A $1,000 investment in BIO five years ago would be worth approximately $468 today, representing a -53.2% return.
Does BIO pay dividends? ▼
No, Bio-Rad Laboratories, Inc. does not currently pay a dividend. The company reinvests its earnings into growth.
What is BIO's market cap? ▼
Bio-Rad Laboratories, Inc. has a market capitalization of $7.1 billion, classifying it as a mid-cap company.
What is BIO's P/E ratio? ▼
BIO has a trailing P/E ratio of 9.4 and a forward P/E of 23.2, which measures how much investors are paying per dollar of earnings.
Is BIO a buy, hold, or sell? ▼
Based on 5 opinions, BIO has a consensus "buy" rating. The average price target is $324.0.
Last updated: 3/14/2026